AI Medical Service Raises $70M for Global Endoscopic AI Expansion
AI Medical Service Inc. (AIM) has secured $70 million in its Series C financing round, led by SoftBank Vision Fund 2 (SVF2). The company aims to boost global adoption of endoscopic AI with the raised funds.
The funding round saw participation from existing investors such as Globis Capital Partners, World Innovation Lab (WiL), and Incubate Fund. Notably, Insight Partners joined as a new investor in April 2022, contributing to the development of AIM's cloud platform for endoscopic AI.
AIM plans to use the funds to accelerate global adoption of its endoscopic AI technology. The company also intends to develop an in-house cloud-based platform to support its AI services, further expanding its capabilities.
AI Medical Service Inc. raised $70 million in its Series C round, with SoftBank Vision Fund 2 leading the investment. The funds will support AIM's mission to advance endoscopic AI globally and develop an in-house cloud platform.
